Internalization and infectivity of Trypanosoma cruzi trypomastigotes by macrophages is enhanced by prior treatment of parasites with normal human serum. Heating serum or removing Clq from serum abrogates the enhancement, but augmentation of attachment and infectivity is restored by addition of purified Clq to either serum source. Although both noninfective epimastigotes (Epi) Although trypomastigotes produce an inhibitor of the complement cascade which limits C3 deposition during incubation in normal human serum, Clq binds to the parasite and enhances entry of trypomastigotes into target cells.
Introduction
Infection of monocytes and macrophages by Leishmania spp.
(1-3), Legionella pneumophila (4) , Mycobacterium tuberculosis (5) , and Histoplasma capsulatum (6) is blocked with monoclonal antibodies to receptors for the third component of complement, CR1 and CR3. Furthermore, productive infection of macrophages by these organisms is markedly enhanced by incubation of the organisms in serum before allowing cell attachment and entry to proceed. These findings, which are most thoroughly developed with Leishmania major (2, 3) and Leishmania donovani (1) , have led to the notion that C3 fragments deposited during incubation in serum or derived from local production by macrophages (7, 8) are necessary for cell attachment and entry. An alternative mechanism has now been proposed for serum-independent uptake of Leishmania mexicana via CR3 (9) . Nonetheless, the central involvement of CR 1 and CR3 has only been postulated for organisms with an obligatory residence in professional phagocytic cells.
Trypanosoma cruzi, the causative agent of Chagas disease, is an intracellular parasite closely related to Leishmania spp., but with a broad host cell range (reviewed in Zingales and Colli [10] (10) .
The ligands and receptors involved in cell uptake of T. cruzi trypomastigotes following serum incubation are not defined. Nogueira and Cohn ( 1) suggested that C3 receptors were not involved in the uptake process, since trypsinization of macrophages did not affect trypomastigote attachment but did diminish binding of complement-coated erythrocytes. In more recent studies by our laboratory (Rimoldi, M. T., and K. A. Joiner, unpublished observations) and others (12) , treatment of trypomastigotes with serum augmented uptake into human and mouse macrophases, but the augmentation was not blocked using monoclonal antibodies directed against CR1 and CR3. In contrast, uptake of non-infective epimastigotes after autologous serum incubation is significantly inhibited by anti-CR3 antibodies. These findings are reflective of the difference in deposition of C3 on the parasite surface during incubation in serum. Epi bear large numbers of C3 molecules after serum incubation (I13-15), whereas deposition of C3 on the trypomastigote surface is limited by a C3 convertase inhibitor produced by this stage (16) (17) (18) .
We therefore sought another explanation for the serummediated enhancement of internalization of trypomastigotes into phagocytic cells. We report here that complement component C 1 q enhances invasion of human mononuclear phagocytes and fibroblasts by trypomastigotes of T. cruzi.
Methods
Buffers and reagents. The following buffers were used: Hanks' buffered salt solution (HBSS) containing 10 mg/ml bovine serum albumin (BSA) (Boehringer-Mannheim) (HBSS-BSA); HBSS containing 20 mg/ml sucrose (HBSS-S); RPMI-1640 (Gibco Laboratories, Grand Island, NY) containing 2 mM glutamine and 10 mg/ml BSA; HL1 When analyzed by SDS-PAGE under reducing conditioning, > 95% of the fibronectin migrated as a band of 200-220 kD. The peptide arginine-glycine-aspartic acid-seine (RGDS) was purchased (Peninsula Laboratories, Inc., Belmont, CA). The peptide gave a single peak when analyzed by high-performance liquid chromatography (LKB Instruments, Inc., Gaithersburg, MD) using a reverse-phase C 18 column (Altex, Berkeley, CA).
Parasites. The Y strain and the Miranda 88 (M88) clone of T. cruzi were obtained from Dr. J. A. Dvorak (Bethesda, MD). The Epi were maintained by serial passage in liver-infusion tryptose broth, (Oxoid, Basingstoke, Hanks, UK) containing 10% (vol/vol) fetal calf serum, 0.02 mg/ml hemin; 100 M/ml penicillin, and 100 ,g/ml streptomycin.
Epi in log-phase growth (3 d) were harvested at a parasite density of 5 X 106/ml. M88 clone TCT were maintained by serial passages in bovine embryo skin muscle cell (BESM) cultures in RPMI-1640 containing 2% fetal calf serum, using culture conditions previously described (17) . Y strain tissue culture trypomastigotes (TCT) were grown in LLCMK2 cells as described (17, 18) . The final suspensions from BESM or LLCMK2 cultures consisted predominantly of motile trypomastigotes; amastigotes and intermediate developmental forms were always present but never exceeded 5% of the total suspension.
Serum. Normal human sera (NHS) were collected and frozen in aliquots at -70°C. Some samples of serum were heated at 56°C for 30 min to inactivate complement (HINHS). Human serum was also depleted of Clq and factor D (Clq D serum) using a BioRex 70 column (Bio-Rad Laboratories, Richmond, CA) at pH 7.3 as described (19) . The absence of Clq was verified by hemolytic titer as described by Kolb et al. (20) . This method can detect < 0.4 ng Clq. Human AB serum was collected from a normal volunteer and heated at 56°C for 30 min. Neither sera contained detectable antibodies for T. cruzi as measured by indirect immunofluorescence at a dilution of 1:10.
Purification and radiolabeling ofCl subcomponents. Cl q was isolated from human serum or plasma as described previously (19) and radiolabeled with Na 1251 (Amersham International, Arlington Heights, IL) to an average specific radioactivity of 0.5 MC/Mg. Purified Clq gave one band on SDS-PAGE. When tested by double immunodiffusion, purified Clq gave no line when tested against antiserum to high density lipoprotein, to "Cruzin," the serum inhibitor of T. cruzi neuraminidase (21) (antiserum kindly provided by M. E. A. Pereira, Tufts University, Boston, MA), or to fibronectin. Clr, Cls, and Cl inhibitor were isolated as previously described (22) (23) (24) . Cls was radioiodinated in the presence of 5 mM CaCl2 (25) stopped by the addition of equal volumes of SDS-PAGE sample buffer containing 15 mM dithiothreitol and incubated for 45 min at 37°C. Cl activation was assayed by SDS-PAGE under reducing conditions as previously described (26) . In some experiments, 107 or 2 X 107 parasites were incubated in a volume of HBSS-BSA identical to that of the '251IC I for 10 min at 30°C. Parasites were pelleted, and the supernatant was assayed for its ability to activate C1 in the presence and absence ofC I Inh. Control tubes contained aggregated IgG (1 mg/ml) in the presence or absence of C I inhibitor.
Degradation ofClq by T. cruzi. A volume of 95 pl containing 2.5 X 10o parasites/ml (M88 clone) was mixed with 5 AI (20 (27) as described (28) . Macrophages, as defined here for the serum-free experiments, were elutriated monocytes that had been cultured in Teflon jars (Savillex Corp., Minnetonka, MN) at 1 X 106 cells/ml in HLl containing 2 mM L-glutamine and 10 ,ug/ml ofgentamicin in 5% CO2 at 370C. On day 7 of culture, macrophages were harvested from the Teflon jars by vigorous pipetting and washed twice in PBS before use. Effector cells (monocytes or macrophages) were suspended in RPMI-1640 medium containing 2 mM L-glutamine, 5 mM MgCl, and 10 Ag/ml gentamicin at 2.5 X 105/ml, and 250 Ad (6.25 X 104 cells) was added to each well of a Lab-Tek chamber previously coated with BSA (40 jig/ml). The cells were allowed to adhere for 1 h at 370C in 5% CO2. TCT or Epi (M88 clone) at 1 X 108/ml were pretreated for 15 min at 00C with Clq (200 jig/ml), washed twice at 40C, and added in a parasite/mononuclear cell ratio of 10: 1. Chambers were centrifuged at room temperature for 3 min at 100 g and were incubated for 30 min at 370C in 5% CO2. Noninternalized parasites were removed by hypotonic lysis with HLB. After fixation with PBS-glutaraldehyde and staining with Giemsa, internalization was determined by light microscopy.
Internalization ofT. cruzi by monocytes or macrophages adhered in the presence or absence of Clq. Eight-well Lab-Tek chambers (Miles Laboratories, Naperville, IL) were incubated with Clq (30 ,ug/ml) or BSA (40 jig/ml) in 0.1 M carbonate buffer, pH 9.5, for 2 h at room temperature. Chambers were washed twice with PBS immediately before use.
Monocytes and macrophages, prepared as described above, were added and allowed to adhere for 1 h at 37°C in 5% CO2. The experiments were performed by adding parasites (M88 clone) at a parasite/ cell ratio of 10:1.
Attachment of T. cruzi-bearing Clq to human foreskin fibroblasts.
Human foreskin fibroblasts were obtained from the American Type Culture Collection, Rockville, MD (ATCC No. CRL 1635) and maintained at low passage number in Eagle's minimal essential medium containing 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 jg/ml streptomycin. For use in experiments, cells were released with trypsin/EDTA and plated overnight on glass coverslips (12 mm, No. 1, Fisher Scientific Co., Pittsburgh, PA) at 2 X104 cells per coverslip. TCT or Epi in PBS at 2 X 107/ml were pretreated for 15 min at 0°C with buffer or (a) Clq at 100 ug/iml, (b) Clq (100 ig/ml) and RGDS (50 jig/ml), (c) human plasma fibronectin at 100 ig/ml, or (d) human plasma fibronectin (100 Ag/ml) and RGDS (50 ;ig/ml).
Parasites were washed'twice at 4°C in PBS. Aliquots of the sample from a were suspended in PBS and incubated for an additional 20 min in buffer alone or buffer containing 200 jg/ml of the F(ab')2 fragment of anti-Clq prepared as described earlier (29) . All parasite preparations were added to fibroblasts on coverslips in 24-well plates at a 20:1 parasite/cell ratio. Plates were centrifuged at room temperature for 3 min at 100 g and incubated for 60 min at 37°C in 5% CO2. Total cell-associated parasites were determined by washing coverslips six times in PBS followed by fixation with PBS glutaraldehyde and staining with Leukostat. Internalized parasites were assessed by first removing noninternalized parasites with HLB.
Attachment ofT. cruzi to humanforeskin fibroblasts plated on CJq.
Human foreskin fibroblasts were plated on coverslips precoated with either buffer, Clq alone, or Clq followed by anti-C lq. Coating with Clq was exactly as described for macrophages and monocytes. Subsequent incubation with F(ab')2 anti-Clq (200 ig/ml) was carried out for 30 min at 4°C after first washing away nonbound Clq; then unbound antibody was removed by washing. Parasites were added at a 20:1 parasite/cell ratio, and further incubations carried out as described above.
Results
Uptake of TCT by macrophages: effect ofincubation in serum.
Initial experiments showed that uptake of TCT by macrophages was augmented by incubation in normal human serum (Fig. 1) . Heating serum or depleting serum ofClq and factor D abrogated the serum mediated enhancement of cell entry (Fig.  1) . When heated serum or Cl q and f) deficient serum were Activation of Cl by T. cruzi. We examined the ability of Epi and TCT to activate human C I which had been reconstituted from purified components (CIq, C Ir2, 1251_C ISA) Fig. 4 shows that while Cl was activated by aggregated IgG, as detected by the shift of radioactivity from the 87-kD proenzyme Ci1s polypeptide chain to the 59-kD chain resulting from cleavage ofCl1s, no Cl1 activation was found during incubation with either Epi or TCT. Instead, a decrease in intensity ofthe 87-kD band was seen, with the appearance of multiple lower molecular weight degradation fragments. This degradation of Cls, which was more extensive with TCT (65% cleavage by densitometric scanning) than with Epi (43% cleavage), occurred in the presence and absence ofCl inhibitor and in the presence ofthe serine esterase inhibitor NPGB (data not shown (Fig. 5 A) . The extent of enhancement was similar when macrophages were used as the target cell (Fig. 5  B) . No differences were found when Epi bearing Clq were compared with Epi alone for entry into monocytes (Fig. 5 A) or macrophages (Fig. 5 B) .
Internalization of T. cruzi by monocytes and macrophages:
effect ofplating cells on Clq. We tested whether plating monocytes or macrophages on Cl q-coated surfaces enhanced parasite internalization, analogous to the effects of Clq on enhancing phagocytosis of other particles (28) . A marked enhancement of internalization of TCT but not Epi resulted when monocytes were adhered to Clq-coated surfaces (Fig. 6  A) . The percentage of internalization and the internalization index were increased 2.4-and 3.7-fold, respectively, when TCT entry into monocytes adhered to Clq-coated surfaces was compared to entry into cells adhered onto BSA-coated surfaces (Fig. 6 A) . In contrast, when Epi were used as target cells, no significant increase in either percentage of internalization or internalization index was found with monocytes adhered to a Clq-coated surface (Fig. 6 A) . Results for TCT were similar when macrophages were adhered to Clq-coated wells (Fig. 6 B) . TCT-Clq were used to infect the monocytes, the mean values differ significantly from the mean value of the control at the P < 0.0 1. No differences were found when Epi treated with Clq were compared with native Epi for internalization by monocytes. When TCT pretreated with Clq were used to infect macrophages, internalization was enhanced significantly in comparison to non-pretreated TCT. Internalization of Epi by macrophages was not significantly enhanced by pretreatment with Clq (0.1 < P < 0.2). Results were similar for all conditions when parasite/cell ratios of 5:1 and 20:1 were compared with the data presented here (not shown).
Clq. Both the percentage ofcells associated with parasites (Fig.  7 a) and the total number of parasites/100 cells (Fig. 7 b) were enhanced. Results were not altered by inclusion of the peptide RGDS with the parasites during incubation with C lq. Incubation of Clq-coated parasites with F(ab')2 anti-Clq significantly decreased the percentage of cells associated with parasites and the total number of parasites per 100 cells. Fibronectin also enhanced attachment of both Epi and TCT to fibroblasts, an effect blocked by RGDS.
In contrast to results with attachment, internalization of TCT but not Epi was augmented by C lq and fibronectin (Fig.  7 c) . These findings are analogous to the results with monocytes and macrophages (Fig. 5) .
Attachment and internalization of T. cruzi by human foreskinfibroblasts plated on Clq. Attachment of Epi and TCT to fibroblasts was not altered when cells were plated on Clqcoated surfaces or Clq and anti-Clq-coated surfaces (Table I) were added to cells adhered to a C lq-coated surface was the mean value significantly different from the mean value of the control at the P < 0.01 level. No significant differences were found in the case of Epi. When TCT were used to infect macrophages plated on Clq, the mean values differ significantly from the mean value of the control at the P < 0.005. Internalization of Epi by macrophages plated on Clq was not enhanced in comparison to macrophages adhered to BSA, but was augmented in comparison to buffer (P < 0.02).
face receptor, or the interaction of ligand with its cell receptor can influence an unrelated opsonic receptor to enhance internalization. This latter mechanism appears to operate for the Cl q-mediated enhancement of phagocytosis of erythrocytes bearing IgG (28) . For T. cruzi, it is likely that Clq serves a similar function with phagocytic cells, since enhanced internalization ofTCT by monocytes or macrophages was observed when either the parasites were opsonized with CIq (Fig. 5) or the human phagocytes were plated on Clq (Fig. 6) . With fibroblasts, Clq functions only as a ligand for attachment (Fig. 7) , since plating cells on Clq does not augment TCT internalization (Table I) .
Interaction of Clq with fibronectin (32-37) may also enhance parasite entry. Treponema pallidum presensitized with Clq showed increased adherence to fibronectin coated surfaces, although phagocytosis by neutrophils was not enhanced (38) . Sorvillo lished observations). Whether or not fibronectin or other extracellular matrix proteins are involved, our results differ from those previously reported (28, 32, 38, 39) , since purified Clq alone potentiates internalization of TCT without an additional requirement for C3 fragments or IgG on the target particle. The collagen-like tail domain of Cl q mediates the enhancement of phagocytosis of particles by monocytes and macrophages (28) . In normal human serum, however, C1 exists as a loosely associated macromolecular complex composed of Clq, Clr2, Cls2 (reviewed in Cooper [44] ) in which the cell-binding region of the collagen-like tail region of C I q is not exposed. Activation of C 1, which is initiated by interaction of the globular head regions of C I q with the activating surface, renders the C r2s2 enzyme susceptible to inactivation by the serum regulatory glycoprotein, Cl inhibitor. In this process, C inhibitor dissociates C r2, C 1 s2 from the C I q-activator complex, thereby exposing the collagen-like tail domain of Clq to the microenvironment (44) (45) (46) (47) . Although conventional activation was not observed in this in vitro system, proteolytic degradation of native Cl by TCT and Epi (Fig. 4 (27) . Finally, it remains to be determined if both C Is and C 1 q degradation occur in normal serum or plasma.
Serum components other than Clq and fibronectin enhance trypomastigote invasion of cultured cells. Protease (48), phospholipase D (49), the serum lipoprotein cruzin (21) , and specific antibodies (50), the first three of which are present in normal serum, also enhance infection. In at least one report, inclusion of fetal calf serum in the assay decreased attachment and invasion of LLCMK2 cells by TCT (31), whereas other workers report an increase in internalization with both calf and human serum (51) . Given the complex interplay among C lq, extracellular matrix proteins, and TCT, it is unlikely that only one serum component will mediate the enhanced trypomastigote invasion after serum incubation. Nonetheless, our results indicate that a substantial portion of the enhanced invasion following serum treatment is due to Clq.
These results with T. cruzi contrast dramatically with those for infection of cells by related Leishmania spp. Attachment and infectivity of metacyclic promastigotes of L. major is enhanced by serum treatment (2, 52) . In this instance, however, enhancement is due to high-level deposition of C3 on the promastigote surface during serum incubation (53) and the subsequent interaction of bound C3 fragments with CR1 (52) or CR3 on macrophages. The fundamental difference in the mechanism of serum resistance between infective forms of T. cruzi and L. major may thus dictate, at least in part, the ligand receptor interactions and the host-cell range which lead to cell invasion. Leishmania spp., which resist serum killing at the terminal portion of the complement cascade, bear large numbers of C3 fragments after serum incubation (53) and are thus suited to enter their obligatory host cell, the macrophage, via receptors for C3. Trypomastigotes of T. cruzi, which produce a C3 convertase inhibitor that prevents deposition of C3 (15) (16) (17) (18) but not of Clq during serum treatment, are directed to cells bearing Clq receptors and fibronectin, of which connective tissue cells such as fibroblasts are the prototype (54) .
